GRAZI, Gian Luca
 Distribuzione geografica
Continente #
NA - Nord America 2.555
AS - Asia 1.317
EU - Europa 557
SA - Sud America 138
AF - Africa 18
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.593
Nazione #
US - Stati Uniti d'America 2.540
SG - Singapore 1.016
IT - Italia 151
ID - Indonesia 132
BR - Brasile 116
DE - Germania 102
GB - Regno Unito 89
CN - Cina 87
UA - Ucraina 42
FI - Finlandia 35
HK - Hong Kong 30
NL - Olanda 29
AT - Austria 28
RU - Federazione Russa 27
FR - Francia 18
SE - Svezia 18
TR - Turchia 14
ZA - Sudafrica 11
CO - Colombia 9
CA - Canada 8
AR - Argentina 7
VN - Vietnam 7
IN - India 5
MA - Marocco 5
IE - Irlanda 4
IQ - Iraq 4
LT - Lituania 4
TW - Taiwan 4
UZ - Uzbekistan 4
NZ - Nuova Zelanda 3
AU - Australia 2
BD - Bangladesh 2
BE - Belgio 2
DO - Repubblica Dominicana 2
ES - Italia 2
EU - Europa 2
JM - Giamaica 2
JP - Giappone 2
KR - Corea 2
MX - Messico 2
PY - Paraguay 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
TN - Tunisia 1
Totale 4.593
Città #
Santa Clara 705
Singapore 336
Fairfield 272
Chandler 165
Jakarta 128
Woodbridge 103
Ashburn 94
Houston 92
Princeton 72
Seattle 72
Wilmington 72
Cambridge 58
San Diego 42
Ann Arbor 40
London 32
Helsinki 30
Hong Kong 30
Shanghai 26
Jacksonville 20
Nuremberg 19
Rome 19
Falls Church 16
Portsmouth 16
Ferrara 14
Falkenstein 13
São Paulo 13
Lauterbourg 12
Vienna 10
Beijing 9
Bologna 9
Los Angeles 9
Milan 9
Xian 8
Düsseldorf 7
Hounslow 7
Kilburn 7
Chicago 6
Lubbock 6
Moscow 6
Mountain View 6
Norwalk 6
Redwood City 6
St Petersburg 6
Vicenza 6
Bari 5
Izmir 5
Medellín 5
Padova 5
Redmond 5
Saint Louis 5
Belo Horizonte 4
Boardman 4
Dublin 4
Frankfurt am Main 4
Tashkent 4
Zhengzhou 4
Zhongli District 4
Arezzo 3
Auburn Hills 3
Bắc Giang 3
Casablanca 3
Chía 3
Curitiba 3
Dong Ket 3
Forest City 3
Groningen 3
Guangzhou 3
Hangzhou 3
Hebei 3
Nagpur 3
Nanjing 3
Ottawa 3
Toronto 3
Verona 3
Auckland 2
Baghdad 2
Brasília 2
Brussels 2
Chelyabinsk 2
Chiswick 2
Duque de Caxias 2
Fort Worth 2
Gatchina 2
Harbin 2
Itapipoca 2
Krasnodar 2
Lasino 2
Mexico City 2
Modena 2
Modigliana 2
Modugno 2
Nanchang 2
Ottaviano 2
Parma 2
Perm 2
Pignola 2
Porto Alegre 2
Reutlingen 2
Ribeirão Preto 2
Rio de Janeiro 2
Totale 2.795
Nome #
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 146
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 119
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 113
Early onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation. 98
Tumor Regression Grade After Neoadjuvant Chemoradiation and Surgery for Low Rectal Cancer Evaluated by Multiple Correspondence Analysis: Ten Years as Minimum Follow-up 72
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples 68
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers 57
Comprehensive Characterization of Cancer Driver Genes and Mutations 57
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas 56
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma 53
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics 53
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer 51
Pathogenic Germline Variants in 10,389 Adult Cancers 50
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer 49
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 49
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells 48
The Impact of Hospital Volume on Failure to Rescue after Liver Resection for Hepatocellular Carcinoma: Analysis from the HE.RC.O.LE.S. Italian Registry 47
Renewed considerations on the utility (or the futility) of hepatic resections for breast cancer liver metastases 47
Multiple hepatocellular carcinoma: Long-term outcomes following resection beyond actual guidelines. An Italian multicentric retrospective study 47
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 44
A case report of giant hepatic hemangioma spontaneous regression in adult, non-cirrhotic patient and literature review 44
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparison 42
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 42
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients 41
Genomic and Functional Approaches to Understanding Cancer Aneuploidy 41
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer 41
Benchmarking postoperative outcomes after open liver surgery for cirrhotic patients with hepatocellular carcinoma in a national cohort 41
Primary leiomyoma of the liver in an immunocompetent patient 40
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics 40
FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma 40
Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience 39
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis 37
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 37
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 37
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 37
Multicentre evaluation of case volume in minimally invasive hepatectomy 36
Wnt3a/b-Catenin signaling conditions differentiation of partially exhausted T-effector cells in human cancers 36
Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-α/p300-mediated acetylation of p53 36
The Immune Landscape of Cancer 36
Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 36
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily 35
Laboratory test variability and Model for End-Stage Liver Disease score calculation: effect on liver allocation and proposal for adjustment 35
The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperation 35
Blood transfusions and steatohepatitis are independent risk factors for complications following liver resection for colorectal cancer liver metastases 34
Association of polygenic risk score and bacterial toxins at screening colonoscopy with colorectal cancer progression: A multicenter case-control study 34
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis 32
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery 32
Oncogenic Signaling Pathways in The Cancer Genome Atlas 32
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers 32
Genetically driven CD39 expression shapes human tumor-infiltrating CD8+ T-cell functions 31
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation 31
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation 31
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas 31
Robotic Liver Resections: Application of Difficulty Score Systems to an Initial Experience. Is a Specific Robotic Difficulty Score Necessary? 31
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines 31
Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature 31
ALPPS for primary and secondary liver tumors 31
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 31
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma 30
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation 30
Is it time to develop a robotic difficulty score system? 30
Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral units 30
The peculiar aging of human liver: A geroscience perspective within transplant context 30
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system 29
Outcome of Right Hepatectomies in Patients Older Than 70 Years 29
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era 28
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer 28
Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach 28
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 28
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome 27
Impact of a goal-directed fluid therapy on length of hospital stay and costs of hepatobiliarypancreatic surgery: A prospective observational study 27
Hepatectomy Versus Sorafenib in Advanced Non-Metastatic Hepatocellular Carcinoma: A Real-Life Multicentric Weighted Comparison 27
Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine 26
Coping strategies in intestinal transplantation 26
Down-staging of hepatocellular carcinoma prior to liver transplantation: the power of selection 26
Key components of a hepatobiliary surgery curriculum for general surgery residents: results of the FULCRUM International Delphi consensus 25
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma 25
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases 25
Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver Transplantation 25
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 25
Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study 25
Organ-saving surgery for rectal cancer after neoadjuvant chemoradiation: Analysis of failures and long-term results 24
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population 24
A room for the alpps procedure in patients with HCC 24
Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry 24
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? 23
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 23
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period 23
Liver resection for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis of risk factors for intrahepatic recurrence 22
Prophylaxis for venous thromboembolism after resection of hepatocellular carcinoma on cirrhosis: is it necessary? 22
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 22
Efficacy of MELD score in predicting survival after liver retransplantation 21
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically 21
Can Hepatocellular Carcinoma tumor grade and microscopical vascular invasion be predicted with an artificial neural network? 21
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 21
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma 20
A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies 20
Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice? 20
Twenty-five consecutive isolated intestinal transplants in adult patients: a five-yr clinical experience 20
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients 20
Totale 3.727
Categoria #
all - tutte 77.922
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.922


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016 0 0 0 0 0 0 0 0 0 12 2 2
2020/2021408 4 31 14 5 9 5 0 65 109 31 110 25
2021/2022629 15 114 7 6 13 11 127 73 41 22 58 142
2022/2023798 75 45 8 50 46 398 9 41 64 4 35 23
2023/2024498 38 79 38 22 24 18 14 19 19 8 30 189
2024/20252.540 115 49 326 3 378 394 59 129 402 685 0 0
Totale 5.111